Polymyalgia Rheumatica Drugs Market Size

Market Size in USD Mn

CAGR14.1%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	14.1%
Market Concentration	Medium
Major Players	Sparrow Pharmaceuticals, Novartis Pharmaceuticals, Roche Chugai, Chugai Pharmaceutical, Genentech Inc. and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Polymyalgia Rheumatica Drugs Market Analysis

The polymyalgia rheumatica drugs market is estimated to be valued at USD 303.5 Mn in 2025 and is expected to reach USD 764.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 14.1% from 2025 to 2032.

Market growth can be attributed to the increasing geriatric population worldwide who are at a higher risk of developing polymyalgia rheumatica and rising awareness among people about the disease.